Printer Friendly

SEISMED INSTRUMENTS ANNOUNCES FIRST QUARTER RESULTS

 MINNEAPOLIS, Feb. 16 /PRNewswire/ -- Seismed Instruments Incorporated (NASDAQ: SEIS) today announced sales and net income for the first quarter ended Dec. 31, 1992. Net sales for the quarter ended Dec. 31, 1992, were $25,600. The company reported a net loss for the quarter ended Dec. 31, 1992 of $547,399, or $.10 per share.
 The net loss was 42.1 percent less than the loss one year ago, however, sales were also less than a year ago. The company continues to implement cost containment measures including a recent staffing reduction from 20 to 15 employees. This is in line with the company's increased focus on research and product development and de-emphasis of sales and marketing activities pending resolution of reimbursement and other market acceptance issues.
 The company's initial strategy was the development of the SCG-2000 for the stress testing market. Market response has indicated that a combined stress electrocardiograph/seismocardiograph system will be a much more highly competitive product. The company has now designed the SE-4000 to meet this market need and plans to introduce the first prototype of the new stress system at the annual meeting of the American College of Cardiology in March 1993. This also coincides with the March publication of a national multicenter study on stress seismocardiography.
 The company has also refocused its clinical research efforts in two new market areas: evaluation of patients with dual-chambered pacemakers and analysis of cardiac function in patients with congestive heart failure. These new areas of clinical research are based on the company's patented core technology.
 Seismed Instruments completed a follow on public offering in the first quarter which netted $2.0 million. The offering was completed through the investment banking firm of Miller, Johnson & Kuehn. Seismed Instruments stock is traded on the NASDAQ Small-Cap market under the symbol SEIS.
 SEISMED INSTRUMENTS INCORPORATED
 First Quarter Ended
 12/31/92 12/31/91
 Net sales $25,600 $54,593
 Net loss (547,399) (946,187)
 Loss per share $(.10) $(.29)
 Average common shares outstanding 5,371,776 3,269,868
 -0- 2/16/93
 /CONTACT: Sandra J. Hollenhorst, president and CEO of Seismed Instruments, 612-473-5151/
 (SEIS)


CO: Seismed Instruments Incorporated ST: Minnesota IN: MTC SU: ERN

KH -- MN009 -- 6790 02/16/93 10:07 EST
COPYRIGHT 1993 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1993 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Feb 16, 1993
Words:375
Previous Article:VALSPAR REPORTS FIRST QUARTER RESULTS
Next Article:IMMUNOGEN, INC. NAMES ROBERT E. TELLIS VICE PRESIDENT OF CORPORATE DEVELOPMENT
Topics:


Related Articles
SEISMED INSTRUMENTS ELECTS NEW BOARD MEMBER
SEISMED INSTRUMENTS ANNOUNCES RESULTS
STERIS REPORTS RECORD FINANCIAL RESULTS IN FISCAL 1993 FIRST QUARTER
SEISMED INSTRUMENTS REPORTS THIRD QUARTER RESULTS
SEISMED INSTRUMENTS INCORPORATED STOCK WILL CONTINUE TO BE LISTED ON NASDAQ SMALL-CAP MARKET SYSTEM
SEISMED INSTRUMENTS INCORPORATED ANNOUNCES CORPORATE DEVELOPMENTS
SEISMED INSTRUMENTS ANNOUNCES EXCEPTION EXTENSION FROM NASDAQ REQUIREMENTS AND ACCEPTANCE OF MULTICENTER STUDY FOR PUBLICATION
SEISMED INSTRUMENTS COMPLETES OFFERING AND PUBLICATION OF CLINICAL RESULTS
SEISMED INSTRUMENTS APPOINTS NEW CHIEF EXECUTIVE OFFICER
ConMed Corporation Has An Increase of 41% in Earnings Per Share.

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters